Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Multiomic neuropathology improves diagnostic accuracy in pediatric neuro-oncology.

Dominik Sturm | David Capper | Felipe Andreiuolo | Marco Gessi | Christian Kölsche | Annekathrin Reinhardt | Philipp Sievers | Annika K Wefers | Azadeh Ebrahimi | Abigail K Suwala | Gerrit H Gielen | Martin Sill | Daniel Schrimpf | Damian Stichel | Volker Hovestadt | Bjarne Daenekas | Agata Rode | Stefan Hamelmann | Christopher Previti | Natalie Jäger | Ivo Buchhalter | Mirjam Blattner-Johnson | Barbara C Jones | Monika Warmuth-Metz | Brigitte Bison | Kerstin Grund | Christian Sutter | Steffen Hirsch | Nicola Dikow | Martin Hasselblatt | Ulrich Schüller | Nicolas U Gerber | Christine L White | Molly K Buntine | Kathryn Kinross | Elizabeth M Algar | Jordan R Hansford | Nicholas G Gottardo | Pablo Hernáiz Driever | Astrid Gnekow | Olaf Witt | Hermann L Müller | Gabriele Calaminus | Gudrun Fleischhack | Uwe Kordes | Martin Mynarek | Stefan Rutkowski | Michael C Frühwald | Christof M Kramm | Andreas von Deimling | Torsten Pietsch | Felix Sahm | Stefan M Pfister | David T W Jones
Nature medicine | 2023

The large diversity of central nervous system (CNS) tumor types in children and adolescents results in disparate patient outcomes and renders accurate diagnosis challenging. In this study, we prospectively integrated DNA methylation profiling and targeted gene panel sequencing with blinded neuropathological reference diagnostics for a population-based cohort of more than 1,200 newly diagnosed pediatric patients with CNS tumors, to assess their utility in routine neuropathology. We show that the multi-omic integration increased diagnostic accuracy in a substantial proportion of patients through annotation to a refining DNA methylation class (50%), detection of diagnostic or therapeutically relevant genetic alterations (47%) or identification of cancer predisposition syndromes (10%). Discrepant results by neuropathological WHO-based and DNA methylation-based classification (30%) were enriched in histological high-grade gliomas, implicating relevance for current clinical patient management in 5% of all patients. Follow-up (median 2.5 years) suggests improved survival for patients with histological high-grade gliomas displaying lower-grade molecular profiles. These results provide preliminary evidence of the utility of integrating multi-omics in neuropathology for pediatric neuro-oncology.

Pubmed ID: 36928815 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


GenePattern (tool)

RRID:SCR_003201

A powerful genomic analysis platform that provides access to hundreds of tools for gene expression analysis, proteomics, SNP analysis, flow cytometry, RNA-seq analysis, and common data processing tasks. A web-based interface provides easy access to these tools and allows the creation of multi-step analysis pipelines that enable reproducible in silico research.

View all literature mentions

European Genome phenome Archive (tool)

RRID:SCR_004944

Web service for permanent archiving and sharing of all types of personally identifiable genetic and phenotypic data resulting from biomedical research projects. The repository allows you to explore datasets from numerous genotype experiments, supplied by a range of data providers. The EGA''s role is to provide secure access to the data that otherwise could not be distributed to the research community. The EGA contains exclusive data collected from individuals whose consent agreements authorize data release only for specific research use or to bona fide researchers. Strict protocols govern how information is managed, stored and distributed by the EGA project. As an example, only members of the EGA team are allowed to process data in a secure computing facility. Once processed, all data are encrypted for dissemination and the encryption keys are delivered offline. The EGA also supports data access only for the consortium members prior to publication.

View all literature mentions